Wanbury Limited (BOM:524212)
India · Delayed Price · Currency is INR 278.65
-5.55 (-1.95%)
At close: Jul 7, 2026
Wanbury Market Cap
Wanbury has a market cap or net worth of 9.72 billion as of July 7, 2026. Its market cap has decreased by -6.02% in one year.
Market Cap
9.72B
Enterprise Value
11.89B
Revenue
6.50B
Ranking
n/a
PE Ratio
14.30
Stock Price
278.65
Market Cap Chart
Since February 7, 2005, Wanbury's market cap has increased from 1.77B to 9.72B, an increase of 449.99%. That is a compound annual growth rate of 8.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 9.72B | 22.67% |
| Dec 31, 2025 | 7.93B | -17.28% |
| Dec 31, 2024 | 9.58B | 121.65% |
| Dec 29, 2023 | 4.32B | 169.44% |
| Dec 30, 2022 | 1.60B | -40.72% |
| Dec 31, 2021 | 2.71B | 135.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fredun Pharmaceuticals | 14.27B |
| Shukra Pharmaceuticals | 13.93B |
| Syncom Formulations (India) | 13.38B |
| TTK Healthcare | 13.00B |
| Lincoln Pharmaceuticals | 12.42B |
| Fermenta Biotech | 10.18B |
| Bharat Parenterals | 9.54B |
| Sudarshan Pharma Industries | 9.50B |